Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 3
1960 1
1968 3
1969 3
1971 1
1975 2
1978 2
1979 1
1984 1
1985 1
1992 1
1993 1
2007 1
2008 1
2010 1
2012 4
2013 6
2014 9
2015 9
2016 6
2017 7
2018 5
2019 1
2020 2
2021 7
2022 12
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Al-Diwani A, Theorell J, Damato V, Bull J, McGlashan N, Green E, Kienzler AK, Harrison R, Hassanali T, Campo L, Browne M, Easton A, Soleymani Majd H, Tenaka K, Iorio R, Dale RC, Harrison P, Geddes J, Quested D, Sharp D, Lee ST, Nauen DW, Makuch M, Lennox B, Fowler D, Sheerin F, Waters P, Leite MI, Handel AE, Irani SR. Al-Diwani A, et al. Among authors: damato v. Brain. 2022 Aug 27;145(8):2742-2754. doi: 10.1093/brain/awac088. Brain. 2022. PMID: 35680425 Free PMC article.
Mechanisms of resistance to mTOR inhibitors.
Formisano L, Napolitano F, Rosa R, D'Amato V, Servetto A, Marciano R, De Placido P, Bianco C, Bianco R. Formisano L, et al. Crit Rev Oncol Hematol. 2020 Mar;147:102886. doi: 10.1016/j.critrevonc.2020.102886. Epub 2020 Jan 29. Crit Rev Oncol Hematol. 2020. PMID: 32014673 Review.
Benefit and danger from immunotherapy in myasthenia gravis.
Rodolico C, Nicocia G, Damato V, Antonini G, Liguori R, Evoli A. Rodolico C, et al. Among authors: damato v. Neurol Sci. 2021 Apr;42(4):1367-1375. doi: 10.1007/s10072-021-05077-6. Epub 2021 Feb 5. Neurol Sci. 2021. PMID: 33543421 Free PMC article. Review.
Myasthenia gravis with antibodies to MuSK: an update.
Evoli A, Alboini PE, Damato V, Iorio R, Provenzano C, Bartoccioni E, Marino M. Evoli A, et al. Among authors: damato v. Ann N Y Acad Sci. 2018 Jan;1412(1):82-89. doi: 10.1111/nyas.13518. Epub 2017 Dec 21. Ann N Y Acad Sci. 2018. PMID: 29266255 Review.
Mechanisms of lapatinib resistance in HER2-driven breast cancer.
D'Amato V, Raimondo L, Formisano L, Giuliano M, De Placido S, Rosa R, Bianco R. D'Amato V, et al. Cancer Treat Rev. 2015 Dec;41(10):877-83. doi: 10.1016/j.ctrv.2015.08.001. Epub 2015 Aug 8. Cancer Treat Rev. 2015. PMID: 26276735 Review.
Approaches for targeting cancer stem cells drug resistance.
Rosa R, D'Amato V, De Placido S, Bianco R. Rosa R, et al. Expert Opin Drug Discov. 2016 Dec;11(12):1201-1212. doi: 10.1080/17460441.2016.1243525. Epub 2016 Oct 14. Expert Opin Drug Discov. 2016. PMID: 27700193 Review.
Serological and experimental studies in different forms of myasthenia gravis.
Vincent A, Huda S, Cao M, Cetin H, Koneczny I, Rodriguez Cruz PM, Jacobson L, Viegas S, Jacob S, Woodhall M, Nagaishi A, Maniaol A, Damato V, Leite MI, Cossins J, Webster R, Palace J, Beeson D. Vincent A, et al. Among authors: damato v. Ann N Y Acad Sci. 2018 Feb;1413(1):143-153. doi: 10.1111/nyas.13592. Epub 2018 Jan 29. Ann N Y Acad Sci. 2018. PMID: 29377162 Review.
81 results